Posted by Michael Wonder on 07 Dec 2020
EMA publishes agenda for 7-10 December CHMP meeting
7 December 2020 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue opinions for the following technologies:
- Remimazolam
- Trastuzumab deruxtecan
- Hepatitis C vaccine
- Fedratinib
- Insulin aspart
- Lenalidomide
- Moxetumomab pasudotox
- Glucagon
- Fostemsavir
- Selpercatinib
- Suntinib maleate
- Tucatinib
- Adalimumab
